Arginine-vasopressin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Arginine-vasopressin, covering 2018-07-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial) [Phase 3]